Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
-
Heritage Distilling Introduces Bitcoin Treasury Policy Statement
-
Compass Diversified Holdings Announces Amendment of its Credit Agreement
-
Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
-
ADDITIONAL RESULTS FROM THE LAPON CANYON PROJECT A NEVADA CANYON OWNED ROYALTY
-
Monster Beverage Announces Webcast Details For Investor Meeting/Business Update January 21, 2025
-
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
-
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
-
Veritex Holdings, Inc. Announces Dates of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
MIND CTI to Acquire Aurenz GmbH
-
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
-
Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
NEXTGEN DIGITAL ANNOUNCES $1.0 MILLION NON-BROKERED PRIVATE PLACEMENT FINANCING
-
Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing
-
Imperial Senior Vice President, Sustainability, Commercial Development and Product Solutions to assume new role at Exxon Mobil Corporation
-
Jeffs’ Brands Presents Estimated Year over Year Growth, Targets $20 million Revenue in 2025, Anticipates over 120% Revenue Growth since its IPO in 2022
-
Swipe-to-Earn Revolution: PAWS Goes Live on XT.COM
-
Immorta Bio to Present New Data on SenoVax™ and StemCell Revivify™ at Biotech Showcase 2025
-
Cmbio® Acquires Eagle Genomics' Assets to Enhance Multi-Omics Software and AI/ML capabilities of its Digital Biology Platform.
-
Balaciano Group Stands with Los Angeles: Offering Support to Residents Affected by Wildfires
-
A Blockbuster Year for Concierge Medicine: Specialdocs Reports a Record 26 Physician-Clients Launched Practices in 2024
-
E2open Announces Fiscal 2025 Third Quarter Financial Results
-
IonQ CEO on Timeline to Quantum Value
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Notification of major shareholding
-
General Counsel Åsa Thunman to leave Sandvik
-
Spectral Capital Welcomes Aaron Christensen as Chief Revenue Officer to Lead Global Expansion of Vogon Cloud Solutions
-
NuRAN Receives CA$ 788,000 Payment of the Arrears
-
From Paymentz to PAIO: a British fintech company underwent a significant global brand refresh
-
Holiverse Digital Twins Transform Healthcar
-
Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
-
Vortex Metals Announces Non-Brokered Private Placement
-
DataMetrex Receives New P.O. for $440k
-
DRB Homes Honored with Nationals Silver Award for Best Builder Website and Gold Award Finalist
-
The Ultimate Credentialing Solution for Independent Practitioners: Transform Your Practice in 2025 With CredyApp Solo
-
Hannover House (HHSE) Positioned for Huge Growth from New Products and Financing
-
Constellation Brands Reports Third Quarter Fiscal 2025 Financial Results
-
CNB Financial Corporation and ESSA Bancorp, Inc. Announce Strategic Merger
-
Golconda Gold Ltd. Announces Appointment of Vikram Kapoor to Board and Equity Grants
-
Net Lease Office Properties Announces Sales of Five Office Properties Totaling $43 Million
-
Alphyn to Present at Upcoming Investor Conferences
-
Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
-
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore
-
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
-
Lazard Hires Stephen Finkel as Managing Director and Global Head of Sports Advisory
-
Gannett to Present at the 27th Annual Needham Growth Conference
-
Churchill Downs Incorporated 2024 Fourth Quarter and Full Year Financial Results Conference Call Invitation
